Search research articles
Contact Us
Filters
Showing results (1561-1570 of 1,813) with videos related to
Page
of 182
Sort By:
The Lancet. Gastroenterology & Hepatology
|
November 19, 2021
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial
Laurent Peyrin-Biroulet, Ailsa Hart, Peter Bossuyt, et al.
The Journal of Trauma and Acute Care Surgery
|
March 15, 2018
RESHAPES: Increasing AAST EGS grade is associated with anastomosis type
Matthew C Hernandez, Brandon R Bruns, Nadeem N Haddad, et al.
Journal of Clinical Neurology (Seoul, Korea)
|
July 7, 2022
[<sup>18</sup>F]THK-5351 PET Patterns in Patients With Alzheimer's Disease and Negative Amyloid PET Findings
Minyoung Oh, Jungsu S Oh, Seung Jun Oh, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
February 28, 2021
Association of Depressive Symptoms With Postoperative Delirium and CSF Biomarkers for Alzheimer's Disease Among Hip Fracture Patients
Carol K Chan, Frederick E Sieber, Kaj Blennow, et al.
JAMA Surgery
|
August 10, 2018
Effect of Depth of Sedation in Older Patients Undergoing Hip Fracture Repair on Postoperative Delirium: The STRIDE Randomized Clinical Trial
Frederick E Sieber, Karin J Neufeld, Allan Gottschalk, et al.
Oncogene
|
September 14, 2004
Mutation of GATA3 in human breast tumors
Jerry Usary, Victor Llaca, Gamze Karaca, et al.
Nature Communications
|
February 15, 2018
Cytosine modifications exhibit circadian oscillations that are involved in epigenetic diversity and aging
Gabriel Oh, Sasha Ebrahimi, Matthew Carlucci, et al.
The Lancet. Gastroenterology & Hepatology
|
November 19, 2021
Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study
Severine Vermeire, Peter L Lakatos, Timothy Ritter, et al.
The Journal of Trauma
|
July 29, 2011
Closing the "care in the air" capability gap for severe lung injury: the Landstuhl Acute Lung Rescue Team and extracorporeal lung support
Raymond Fang, Patrick F Allan, Shannon G Womble, et al.
Neurobiology of Disease
|
November 29, 2008
GSK3 inhibitors show benefits in an Alzheimer's disease (AD) model of neurodegeneration but adverse effects in control animals
Shuxin Hu, Aynun N Begum, Mychica R Jones, et al.
Page
of 182
Search research articles
Search
Showing results (1561-1570 of 1,813) with videos related to
Sort By:
Page
of 182
The Lancet. Gastroenterology & Hepatology
|
November 19, 2021
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial
Laurent Peyrin-Biroulet, Ailsa Hart, Peter Bossuyt, et al.
The Journal of Trauma and Acute Care Surgery
|
March 15, 2018
RESHAPES: Increasing AAST EGS grade is associated with anastomosis type
Matthew C Hernandez, Brandon R Bruns, Nadeem N Haddad, et al.
Journal of Clinical Neurology (Seoul, Korea)
|
July 7, 2022
[<sup>18</sup>F]THK-5351 PET Patterns in Patients With Alzheimer's Disease and Negative Amyloid PET Findings
Minyoung Oh, Jungsu S Oh, Seung Jun Oh, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
February 28, 2021
Association of Depressive Symptoms With Postoperative Delirium and CSF Biomarkers for Alzheimer's Disease Among Hip Fracture Patients
Carol K Chan, Frederick E Sieber, Kaj Blennow, et al.
JAMA Surgery
|
August 10, 2018
Effect of Depth of Sedation in Older Patients Undergoing Hip Fracture Repair on Postoperative Delirium: The STRIDE Randomized Clinical Trial
Frederick E Sieber, Karin J Neufeld, Allan Gottschalk, et al.
Oncogene
|
September 14, 2004
Mutation of GATA3 in human breast tumors
Jerry Usary, Victor Llaca, Gamze Karaca, et al.
Nature Communications
|
February 15, 2018
Cytosine modifications exhibit circadian oscillations that are involved in epigenetic diversity and aging
Gabriel Oh, Sasha Ebrahimi, Matthew Carlucci, et al.
The Lancet. Gastroenterology & Hepatology
|
November 19, 2021
Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study
Severine Vermeire, Peter L Lakatos, Timothy Ritter, et al.
The Journal of Trauma
|
July 29, 2011
Closing the "care in the air" capability gap for severe lung injury: the Landstuhl Acute Lung Rescue Team and extracorporeal lung support
Raymond Fang, Patrick F Allan, Shannon G Womble, et al.
Neurobiology of Disease
|
November 29, 2008
GSK3 inhibitors show benefits in an Alzheimer's disease (AD) model of neurodegeneration but adverse effects in control animals
Shuxin Hu, Aynun N Begum, Mychica R Jones, et al.
Page
of 182